5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
with Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group
The treatment of squamous cell carcinomas of the head and neck is multidisciplinary, especially when...
Five hundred and fifty thousand new head and neck cancer cases are diagnosed each year worldwide.
© 2012 Verein zur Förderung der Wissenschaft -Prävention und Therapie von Kehlkopfkrebs e. V. | imprint | contact | privacy | terms of use